Global Bacterial & Viral Point of Care Biosensors Market Size, Trends & Analysis - Forecasts to 2026 By Portability (Bench-Top & Handheld), By Type of Bacteria (Streptococcus A, Clostridium Difficile, Helicobacter Pylori, and Other Bacteria), By Type of Virus (Corona Virus, Influenza A, Influenza B, Respiratory Syncytial Virus, HPV, Adenovirus, Norovirus, Rotavirus, and Other Viruses), By End-User (Hospital Laboratories, Diagnostic Testing Laboratories, Pharma & Biotech Laboratories, Environmental Research Institutes, and Others), Competitive Landscape, Company Market Share Analysis, and Competitor Analysis
The major reason for the nosocomial infection is caused by the infectious virus. However, the healthcare industry is dealing with the issue of insufficient data available which should allow trend monitoring of viral incidences. A similar issue is faced by bacterial infections in hospitals, public places, community centers, etc. The most vital defences against the nosocomial transfer of viruses lie in continuous public screening for the infection, and constant efforts taken to educate the healthcare staff and imply strict norms of the infection control policies.
Such infections have now become the major reason for the world’s mortality rate in correlation to the economic losses both in developed and developing nations. Hence, advanced and efficientbacterial and virus detection devices/ methodshave now become an important part to understand and studythe prevalence and subsequently collect the data for the same.
Although, due to false sample collection or human errors, the cases of false-positive and false-negative test reports have led to become a market challenge. Also, long turnaround time, high costs, and lack of viral detection systems have given rise to the use of point-of-care bacterial and viral biosensors lately. These biosensors are highly portable, with a quick turnaround time, low-cost. The major players in this field are Randox Laboratories, NanoEntek, PalmSens, Abbott, and Sartorius AG. Biosensors for bacterial presence detection are electrochemical and optical biosensors. For instance, the market has products such as potentiometric, impedance, and amperometric biosensors, which are widely used for research and diagnostic purposes. Moreover, these biosensors are highly sensitive and specific, rapid with quick turnaround time, cost-effective, and perfect for onsite and real-time bacterial detection.
The market will be growing the fastest with double-digit CAGR value mainly due to the rising COVID-19 cases, increasing prevalence of patients with a bacterial infection, increasing healthcare expenditure across both developed and developing nations, rapidly rising awareness regarding point of care analysis for deadly infectious diseases and increasing research activities to launch enhanced and portable biosensors in the market. The rising research projects related to rapid virus tests are the major market driver. For instance, in April 2020, researchers from Swiss Federal Laboratories for Materials Science and Technology (EMPA), had initiated a study to develop and launch a new and novel portable biosensor for detecting the new coronavirus.
Based on portability the market can be segmented into handheld and benchtop biosensors. The handheld will be the rapidly growing segment as compared to the largest shareholder segment- benchtop biosensors. The major reason being, the capability of real-time and on-site bacterial and viral detection and quick turnaround time for test results. Moreover rising COVID-19 cases will propel the growth of the rapid/ handheld biosensors segment in terms of market value from 2021-2026.
Based on the type of bacteria, the market is segmented into Streptococcus A, Clostridium Difficile, Helicobacter Pylori, and other bacterias. The market segment of Streptococcus A will be the largest as compared to other bacterias. Streptococcus A. is the major reason for the most common diseases found in patients. These include pneumonia, skin wound, strep throat, and bloodstream infections. Hence due to the increasing prevalence of diseases like pneumonia and blood-based infections, the segment of Streptococcus A. will be the largest from 2021 to 2026.
Based on the type of virus, the market study is based on Corona Virus, Influenza A, Influenza B, Respiratory Syncytial Virus, HPV, Adenovirus, Norovirus, Rotavirus, and Other Viruses. The segment of Corona Virus will be the rapidly growing one owing to the augment of COVID-19 pandemic across the globe. However, the largest segment will be the Influenza A virus.
The major end-users or customers for these portable biosensors are diagnostic testing laboratories, hospital laboratories, environmental research institutes, pharma & biotech laboratories, and other end-users. The largest segment of this market based on end-user is the diagnostic testing laboratories. With the rising prevalence of viral infection cases and increasing awareness of infectious disease screening, this segment is likely to enjoy the majority of the shares in the market from 2021 to 2026. The second-largest segment is the environmental research laboratories which are engaging deeply in adopting portable and handheld bacterial infection detection that can give them results with quick turnaround time.
As per the geographical analysis, the market can be classified into North America (the United States, Canada, and Mexico), Asia Pacific (India, China, Japan, Malaysia, Singapore, and Rest of Asia Pacific), Europe (Germany, United Kingdom, Italy, France, Spain, Netherlands, and Rest of Europe), Middle East & Africa (Saudi Arabia, United Arab Emirates, and Rest of the Middle East & Africa) and Central South America (Brazil, Argentina, and Rest of Central and South America).Owing to the fact that the headquarter of the top companies in the biosensors market are in the US, the market for North America will be dominant throughout the forecast period. However, due to a major outbreak of COVID-19 viral infection in India and China, the Asia Pacific market will be growing the fastest from 2021 to 2026.
Aidian Oy, Alere, Association of Medicine and Analytics, BD, Biogal – Galed Laboratories, Credo Biomedical Pte Ltd., Delta Electronics, GenMark Diagnostics, NanoEntek, Zhongshan Chuangyi Biochemical, Randox Laboratories, NanoEntek, PalmSens, Abbott, and Sartorius AG among others are the players in the bacterial & viral point of care biosensors market.
Please note: This is not an exhaustive list of companies profiled in the report.
We value your investment and offer free customization with every report to fulfil your exact research needs.
The Global Bacterial & Viral Point of Care Biosensors Market has been studied from the year 2019 till 2026. However, the CAGR provided in the report is from the year 2021 to 2026. The research methodology involved three stages: Desk research, Primary research, and Analysis & Output from the entire research process.
The desk research involved a robust background study which meant referring to paid and unpaid databases to understand the market dynamics; mapping contracts from press releases; identifying the key players in the market, studying their product portfolio, competition level, annual reports/SEC filings & investor presentations; and learning the demand and supply-side analysis for the Bacterial & Viral Point of Care Biosensors Market.
The primary research activity included telephonic conversations with more than 50 tier 1 industry consultants, distributors, and end-use product manufacturers.
Finally, based on the above thorough research process, an in-depth analysis was carried out considering the following aspects: market attractiveness, current & future market trends, market share analysis, SWOT analysis of the company and customer analytics.
Tailor made solutions just for you
80% of our clients seek made-to-order reports. How do you want us to tailor yours?